Clinical Trial Update: Fosfomycin Plus Imipenem for Treatment of Infective Endocarditis [Phase 4]

View source ↗

Summary

This document reports the completion of a Phase 4 clinical trial evaluating the combination of fosfomycin and imipenem for treating infective endocarditis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infective Endocarditis

Drugs mentioned

• Fosfomycin (Fosfomycin)
• Imipenem

Snippet

Sponsor: Juan A. Arnaiz | Conditions: Infective Endocarditis | Phase 4 | Status: COMPLETED